Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
Commentary|Videos|April 10, 2026
Protecting Athletes in an Era of High-Risk Supplements
Travis Tygart, JD, discusses the growing risks of supplements and the critical need for education and vigilance to protect athletes and uphold clean sport.
Advertisement
At the Sports Pharmacy Summit, Pharmacy Times spoke with Travis Tygart, JD, CEO of the United States Anti-Doping Agency, about the growing challenges surrounding supplement use, high-risk substances, and athlete safety. Tygart highlighted the increasing complexity of the supplement landscape, emphasizing how easily athletes can be exposed to banned or contaminated products. He underscored the importance of education, transparency, and vigilance in maintaining clean sport, particularly as new substances and trends continue to emerge.
Advertisement
Related to this article
Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
Experts on Lp(a) testing, statin myths, cognitive safety, and the 2025-2030 Dietary Guidelines share counseling points from the National Lipid Association's Fall Clinical Lipid Update meeting.
Eric Lawitz, MD, explains how pharmacists can discuss liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
VAX-31 met all primary end points against PCV20 and PCV21 in the pivotal phase 3 OPUS-1 trial.
A year after FDA approval in heart failure (HF) with LVEF of 40% or higher, new ACC guidance and trial subanalyses are shaping how pharmacists use finerenone.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Researchers Target Viral Fusion for Universal Flu, HIV Vaccines
3
5 Breast Cancer Advances in 2026—And The Questions They Leave Unanswered
4
Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch
5